Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

Mohammed Salah Ayoup; Islam Shawki; Hamida Abdel-Hamid; Doaa A. Ghareeb; Aliaa Masoud; Marwa F. Harras; Mohamed El-Atawy; Nuha Salamah Alharbi; Magda M. F. Ismail

doi:10.1039/D4RA90066A

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

Mohammed Salah Ayoup,*^ab Islam Shawki,^b Hamida Abdel-Hamid,^b Doaa A. Ghareeb,^cg Aliaa Masoud,^c Marwa F. Harras,^d Mohamed El-Atawy,*^be Nuha Salamah Alharbi^f and Magda M. F. Ismail^d

Author affiliations

* Corresponding authors

^a Department of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia
E-mail: mayoup@kfu.edu.sa, mohammedsalahayoup@gmail.com

^b Department of Chemistry, Faculty of Science, Alexandria University, Alexandria, Egypt
E-mail: mohamed.elatawi@alexu.edu.eg

^c Bio-Screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt

^d Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11754, Egypt

^e Chemistry Department, College of Science at Yanbu, Taibah University, Yanbu 46423, Saudi Arabia

^f Chemistry Department, College of Sciences, Taibah University, Al-Madina 30002, Saudi Arabia

^g Center of Excellence for Drug Preclinical Studies (CE-DPS), Pharmaceutical and Fermentation Industry Development Center, City of Scientific Research & Technological Applications (SRTA-city), New Borg El Arab, Alexandria, Egypt

Abstract

Correction for ‘Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles’ by Mohammed Salah Ayoup et al., RSC Adv., 2024, 14, 16713–16726, https://doi.org/10.1039/D4RA02222J.

Associated articles

Article information

DOI: https://doi.org/10.1039/D4RA90066A
Article type: Correction
Submitted: 29 May 2024
Accepted: 29 May 2024
First published: 05 Jun 2024
This article is Open Access

Download Citation

RSC Adv., 2024,14, 17945-17945

Permissions

Request permissions

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

M. S. Ayoup, I. Shawki, H. Abdel-Hamid, D. A. Ghareeb, A. Masoud, M. F. Harras, M. El-Atawy, N. S. Alharbi and M. M. F. Ismail, RSC Adv., 2024, 14, 17945 DOI: 10.1039/D4RA90066A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

RSC Advances

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

Social activity

Search articles by author

Spotlight

Advertisements